Vasamed Inc VSMD:OTCPK

RT Quote | Exchange | USD
Last | 03/02/21 EST
0.0081UNCH (UNCH)
52 week range
0.01 - 0.04

...

Loading . . .

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.0081
  • 52 Week High0.04
  • 52 Week High Date05/15/20
  • 52 Week Low0.01
  • 52 Week Low Date01/20/21
  • Market Cap60,000.00
  • Shares Out8.01M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta1.14
  • 1 Year % Change-32.5

RATIOS/PROFITABILITY

  • EPS (TTM)-0.24
  • P/E (TTM)-0.03
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-1.474M
  • ROE (MRQ)-
  • Revenue (MRQ)3.43M
  • Gross Margin (MRQ)57.73%
  • Net Margin (MRQ)-56.10%
  • Debt To Equity (MRQ)-87.33%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Vasamed Inc News

There is no recent news for this security.

Latest VSMD News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Vasamed Incorporated designs, licenses, manufactures and distributes products, software and services for assessing and managing hemodynamic health. Its SensiLase peripheral arterial disease (PAD)-IQ Studycast System provides measurement of tissue perfusion of the extremities particularly in patients with combined peripheral arterial disease and diabetes. The SensiLase PAD-IQ Studycast supports non-invasive upper and lower extremity vascular assessments, including skin...
Paulita LaPlante
President
Roberta Dircks
Chief Financial Officer
Terry Duesterhoeft
Vice President
Address
7615 Golden Triangle Dr Ste a
Eden Prairie, MN
55344-3733
United States